AbbVie (Q14662364): Difference between revisions

From Wikidata

Jump to navigation Jump to search

Browse history interactively

← Older editNewer edit →

Revision as of 18:52, 9 October 2023 (restore) MatSuBot (talk | contribs) Bots, Rollbackers 12,741,138 edits ‎Changed label, description and/or aliases in uk: add missing labels ← Older edit		Revision as of 07:21, 25 June 2024 (restore) undo Epìdosis (talk | contribs) Administrators 7,758,517 edits ‎Removed claim: WorldCat Identities ID (superseded) (P7859): nc-abbvie%20inc, batch #233255 Tag: quickstatements [2.0] Newer edit →
(40 intermediate revisions by 9 users not shown)
label / eo		label / eo
			AbbVie
description / id		description / id
			perusahaan asal Amerika Serikat
description / zh		description / zh
			美国生物技术公司（AbbVie）
Property / ISNI		Property / ISNI
	0000 0004 0572 4227		0000000405724227
		Property / chief executive officer: Richard A. Gonzalez / qualifier
			start time: 1 January 2013 Timestamp +2013-01-01T00:00:00Z Timezone +00:00 Calendar Gregorian Precision 1 day Before 0 After 0
		Property / chief executive officer: Richard A. Gonzalez / qualifier
			end time: 1 July 2024 Timestamp +2024-07-01T00:00:00Z Timezone +00:00 Calendar Gregorian Precision 1 day Before 0 After 0
Property / chief executive officer: Richard A. Gonzalez / qualifier
	start time: 2013 Timestamp +2013-00-00T00:00:00Z Timezone +00:00 Calendar Gregorian Precision 1 year Before 0 After 0
		Property / chief executive officer: Richard A. Gonzalez / reference
			stated in: Form 8-K reference URL: https://www.sec.gov/Archives/edgar/data/1551152/000104746913000017/a2212291z8-k.htm
		Property / chief executive officer: Richard A. Gonzalez / reference
			stated in: Form 8-K reference URL: https://www.sec.gov/Archives/edgar/data/1551152/000110465924025262/tm246649d1_ex99-1.htm
Property / chief executive officer: Richard A. Gonzalez / reference
	reference URL: https://www.bloomberg.com/research/stocks/people/person.asp?personId=247511&privcapId=141885706
Property / WorldCat Identities ID (superseded)
	nc-abbvie%20inc
Property / WorldCat Identities ID (superseded): nc-abbvie%20inc / rank
	Normal rank
		Property / board member: Richard A. Gonzalez / qualifier
			start time: 1 January 2013 Timestamp +2013-01-01T00:00:00Z Timezone +00:00 Calendar Gregorian Precision 1 day Before 0 After 0
Property / board member: Richard A. Gonzalez / qualifier
	start time: 2013 Timestamp +2013-00-00T00:00:00Z Timezone +00:00 Calendar Gregorian Precision 1 year Before 0 After 0
		Property / board member: Richard A. Gonzalez / reference
			stated in: Form 8-K reference URL: https://www.sec.gov/Archives/edgar/data/1551152/000104746913000017/a2212291z8-k.htm
		Property / board member: Robert Alpern / qualifier
			start time: 1 January 2013 Timestamp +2013-01-01T00:00:00Z Timezone +00:00 Calendar Gregorian Precision 1 day Before 0 After 0
Property / board member: Robert Alpern / qualifier
	start time: 2013 Timestamp +2013-00-00T00:00:00Z Timezone +00:00 Calendar Gregorian Precision 1 year Before 0 After 0
		Property / board member: Robert Alpern / reference
			stated in: Form 8-K reference URL: https://www.sec.gov/Archives/edgar/data/1551152/000104746913000017/a2212291z8-k.htm
		Property / board member: Roxanne Austin / qualifier
			start time: 1 January 2013 Timestamp +2013-01-01T00:00:00Z Timezone +00:00 Calendar Gregorian Precision 1 day Before 0 After 0
Property / board member: Roxanne Austin / qualifier
	start time: 2013 Timestamp +2013-00-00T00:00:00Z Timezone +00:00 Calendar Gregorian Precision 1 year Before 0 After 0
		Property / board member: Roxanne Austin / reference
			stated in: Form 8-K reference URL: https://www.sec.gov/Archives/edgar/data/1551152/000104746913000017/a2212291z8-k.htm
		Property / board member: Willie Burnside / qualifier
			start time: 1 January 2013 Timestamp +2013-01-01T00:00:00Z Timezone +00:00 Calendar Gregorian Precision 1 day Before 0 After 0
Property / board member: Willie Burnside / qualifier
	start time: 2013 Timestamp +2013-00-00T00:00:00Z Timezone +00:00 Calendar Gregorian Precision 1 year Before 0 After 0
		Property / board member: Willie Burnside / reference
			stated in: Form 8-K reference URL: https://www.sec.gov/Archives/edgar/data/1551152/000104746913000017/a2212291z8-k.htm
		Property / board member: Tom Freyman / qualifier
			start time: 8 May 2020 Timestamp +2020-05-08T00:00:00Z Timezone +00:00 Calendar Gregorian Precision 1 day Before 0 After 0
Property / board member: Tom Freyman / qualifier
	start time: 2020 Timestamp +2020-00-00T00:00:00Z Timezone +00:00 Calendar Gregorian Precision 1 year Before 0 After 0
		Property / board member: Tom Freyman / reference
			stated in: Form 8-K reference URL: https://www.sec.gov/Archives/edgar/data/1551152/000110465920058837/tm2018740d2_8k.htm
		Property / board member: Brett Hart / qualifier
			start time: 6 May 2016 Timestamp +2016-05-06T00:00:00Z Timezone +00:00 Calendar Gregorian Precision 1 day Before 0 After 0
Property / board member: Brett Hart / qualifier
	start time: 2016 Timestamp +2016-00-00T00:00:00Z Timezone +00:00 Calendar Gregorian Precision 1 year Before 0 After 0
		Property / board member: Brett Hart / reference
			reference URL: https://www.sec.gov/Archives/edgar/data/1551152/000104746916011386/a2227878zdef14a.htm#Item1
Property / board member: Brett Hart / reference
	reference URL: https://www.sec.gov/Archives/edgar/data/1551152/000104746917001778/a2231406zdef14a.htm
		Property / board member: Melody Meyer / qualifier
			start time: 5 May 2017 Timestamp +2017-05-05T00:00:00Z Timezone +00:00 Calendar Gregorian Precision 1 day Before 0 After 0
Property / board member: Melody Meyer / qualifier
	start time: 2017 Timestamp +2017-00-00T00:00:00Z Timezone +00:00 Calendar Gregorian Precision 1 year Before 0 After 0
		Property / board member: Melody Meyer / reference
			stated in: Proxy Statement reference URL: https://www.sec.gov/Archives/edgar/data/1551152/000104746917001778/a2231406zdef14a.htm#PR3
		Property / board member: Becky Roberts / qualifier
			start time: 4 May 2018 Timestamp +2018-05-04T00:00:00Z Timezone +00:00 Calendar Gregorian Precision 1 day Before 0 After 0
Property / board member: Becky Roberts / qualifier
	start time: 2018 Timestamp +2018-00-00T00:00:00Z Timezone +00:00 Calendar Gregorian Precision 1 year Before 0 After 0
		Property / board member: Becky Roberts / reference
			stated in: Proxy Statement reference URL: https://www.sec.gov/Archives/edgar/data/1551152/000104746918001843/a2234787zdef14a.htm#A3
		Property / board member: Glenn Tilton / qualifier
			start time: 1 January 2013 Timestamp +2013-01-01T00:00:00Z Timezone +00:00 Calendar Gregorian Precision 1 day Before 0 After 0
Property / board member: Glenn Tilton / qualifier
	start time: 2013 Timestamp +2013-00-00T00:00:00Z Timezone +00:00 Calendar Gregorian Precision 1 year Before 0 After 0
		Property / board member: Glenn Tilton / reference
			stated in: Form 8-K reference URL: https://www.sec.gov/Archives/edgar/data/1551152/000104746913000017/a2212291z8-k.htm
		Property / board member: Rick Waddell / qualifier
			start time: 29 November 2012 Timestamp +2012-11-29T00:00:00Z Timezone +00:00 Calendar Gregorian Precision 1 day Before 0 After 0
Property / board member: Rick Waddell / qualifier
	start time: 2013 Timestamp +2013-00-00T00:00:00Z Timezone +00:00 Calendar Gregorian Precision 1 year Before 0 After 0
		Property / board member: Rick Waddell / reference
			stated in: Form 8-K reference URL: https://www.sec.gov/Archives/edgar/data/1551152/000104746913000017/a2212291z8-k.htm
Property / net profit
	3,433,000,000 United States dollar Amount 3,433,000,000 United States dollar Unit United States dollar
Property / net profit: 3,433,000,000 United States dollar / rank
	Normal rank
Property / net profit: 3,433,000,000 United States dollar / qualifier
	point in time: 2011 Timestamp +2011-00-00T00:00:00Z Timezone +00:00 Calendar Gregorian Precision 1 year Before 0 After 0
Property / net profit: 3,433,000,000 United States dollar / reference
	reference URL: https://www.sec.gov/Archives/edgar/data/0001551152/000104746914001154/a2217723z10-k.htm publication date: 21 February 2014 Timestamp +2014-02-21T00:00:00Z Timezone +00:00 Calendar Gregorian Precision 1 day Before 0 After 0 stated in: Form 10-K
Property / net profit
	5,275,000,000 United States dollar Amount 5,275,000,000 United States dollar Unit United States dollar
Property / net profit: 5,275,000,000 United States dollar / rank
	Normal rank
Property / net profit: 5,275,000,000 United States dollar / qualifier
	point in time: 2012 Timestamp +2012-00-00T00:00:00Z Timezone +00:00 Calendar Gregorian Precision 1 year Before 0 After 0
Property / net profit: 5,275,000,000 United States dollar / reference
	reference URL: https://www.sec.gov/Archives/edgar/data/0001551152/000104746915000995/a2223058z10-k.htm publication date: 20 February 2015 Timestamp +2015-02-20T00:00:00Z Timezone +00:00 Calendar Gregorian Precision 1 day Before 0 After 0 stated in: Form 10-K
Property / net profit
	4,128,000,000 United States dollar Amount 4,128,000,000 United States dollar Unit United States dollar
Property / net profit: 4,128,000,000 United States dollar / rank
	Normal rank
Property / net profit: 4,128,000,000 United States dollar / qualifier
	point in time: 2013 Timestamp +2013-00-00T00:00:00Z Timezone +00:00 Calendar Gregorian Precision 1 year Before 0 After 0
Property / net profit: 4,128,000,000 United States dollar / reference
	reference URL: https://www.sec.gov/Archives/edgar/data/0001551152/000104746916010239/a2227341z10-k.htm publication date: 19 February 2016 Timestamp +2016-02-19T00:00:00Z Timezone +00:00 Calendar Gregorian Precision 1 day Before 0 After 0 stated in: Form 10-K
		Property / industry
			biotechnology
		Property / industry: biotechnology / rank
			Normal rank
		Property / legal form
			conglomerate
		Property / legal form: conglomerate / rank
			Normal rank
		Property / chief executive officer
			Robert A. Michael
		Property / chief executive officer: Robert A. Michael / rank
			Normal rank
		Property / chief executive officer: Robert A. Michael / qualifier
			start time: 1 July 2024 Timestamp +2024-07-01T00:00:00Z Timezone +00:00 Calendar Gregorian Precision 1 day Before 0 After 0
		Property / chief executive officer: Robert A. Michael / reference
			stated in: Form 8-K reference URL: https://www.sec.gov/Archives/edgar/data/1551152/000110465924025262/tm246649d1_ex99-1.htm
		Property / product or material produced or service provided
			medical treatment
		Property / product or material produced or service provided: medical treatment / rank
			Normal rank
		Property / board member
			Robert A. Michael
		Property / board member: Robert A. Michael / rank
			Normal rank
		Property / board member: Robert A. Michael / qualifier
			start time: 1 July 2024 Timestamp +2024-07-01T00:00:00Z Timezone +00:00 Calendar Gregorian Precision 1 day Before 0 After 0
		Property / board member: Robert A. Michael / reference
			stated in: Form 8-K reference URL: https://www.sec.gov/Archives/edgar/data/1551152/000110465924025262/tm246649d1_ex99-1.htm
		Property / board member
			Jennifer L. Davis
		Property / board member: Jennifer L. Davis / rank
			Normal rank
		Property / board member: Jennifer L. Davis / qualifier
			start time: 11 October 2023 Timestamp +2023-10-11T00:00:00Z Timezone +00:00 Calendar Gregorian Precision 1 day Before 0 After 0
		Property / board member: Jennifer L. Davis / reference
			stated in: Form 8-K reference URL: https://www.sec.gov/Archives/edgar/data/1551152/000110465923108864/tm2328138d1_8k.htm
		Property / board member
			Susan Quaggin
		Property / board member: Susan Quaggin / rank
			Normal rank
		Property / board member: Susan Quaggin / qualifier
			start time: 11 October 2023 Timestamp +2023-10-11T00:00:00Z Timezone +00:00 Calendar Gregorian Precision 1 day Before 0 After 0
		Property / board member: Susan Quaggin / reference
			stated in: Form 8-K reference URL: https://www.sec.gov/Archives/edgar/data/1551152/000110465923108864/tm2328138d1_8k.htm
		Property / board member
			Edward J. Rapp
		Property / board member: Edward J. Rapp / rank
			Normal rank
		Property / board member: Edward J. Rapp / qualifier
			start time: 1 January 2013 Timestamp +2013-01-01T00:00:00Z Timezone +00:00 Calendar Gregorian Precision 1 day Before 0 After 0
		Property / board member: Edward J. Rapp / reference
			stated in: Form 8-K reference URL: https://www.sec.gov/Archives/edgar/data/1551152/000104746913000017/a2212291z8-k.htm
		Property / Genius artist ID
			Abbvie-formerly-a-division-of-abbott-pharmaceuticals
		Property / Genius artist ID: Abbvie-formerly-a-division-of-abbott-pharmaceuticals / rank
			Normal rank
		Property / Google Scholar organization ID
			12853406975335582193
		Property / Google Scholar organization ID: 12853406975335582193 / rank
			Normal rank
		Property / separated from
			Abbott Laboratories
		Property / separated from: Abbott Laboratories / rank
			Normal rank
		Property / separated from: Abbott Laboratories / qualifier
			start time: 1 January 2013 Timestamp +2013-01-01T00:00:00Z Timezone +00:00 Calendar Gregorian Precision 1 day Before 0 After 0
		Property / separated from: Abbott Laboratories / reference
			stated in: Form 8-K reference URL: https://www.sec.gov/Archives/edgar/data/1551152/000104746913000017/a2212291z8-k.htm
links / eowiki / name		links / eowiki / name
			AbbVie

---

Revision as of 07:21, 25 June 2024

pharmaceutical company

• AbbVie Inc.
• ABBV

Language	Label	Description	Also known as
English	AbbVie	pharmaceutical company	AbbVie Inc. ABBV

Statements

instance of

business

0 references

pharmaceutical company

0 references

public company

1 reference

Wikimedia import URL

https://en.wikipedia.org/wiki/Category:Companies_listed_on_the_New_York_Stock_Exchange

retrieved

21 February 2023

part of

S&P 500

0 references

S&P 100

0 references

industry

pharmaceutical industry

0 references

biotechnology

0 references

inception

1 January 2013

1 reference

reference URL

https://money.cnn.com/quote/profile/profile.html?symb=ABBV

logo image

AbbVie logo.svg
559 × 105; 3 KB

0 references

short name

ABBV (English)

0 references

chief executive officer

Richard A. Gonzalez

start time

1 January 2013

end time

1 July 2024

2 references

stated in

Form 8-K

reference URL

https://www.sec.gov/Archives/edgar/data/1551152/000104746913000017/a2212291z8-k.htm

stated in

Form 8-K

reference URL

https://www.sec.gov/Archives/edgar/data/1551152/000110465924025262/tm246649d1_ex99-1.htm

Robert A. Michael

start time

1 July 2024

1 reference

stated in

Form 8-K

reference URL

https://www.sec.gov/Archives/edgar/data/1551152/000110465924025262/tm246649d1_ex99-1.htm

board member

Richard A. Gonzalez

start time

1 January 2013

2 references

reference URL

https://www.sec.gov/Archives/edgar/data/1551152/000104746917001778/a2231406zdef14a.htm

stated in

Form 8-K

reference URL

https://www.sec.gov/Archives/edgar/data/1551152/000104746913000017/a2212291z8-k.htm

Robert Alpern

start time

1 January 2013

2 references

reference URL

https://www.sec.gov/Archives/edgar/data/1551152/000104746917001778/a2231406zdef14a.htm

stated in

Form 8-K

reference URL

https://www.sec.gov/Archives/edgar/data/1551152/000104746913000017/a2212291z8-k.htm

Roxanne Austin

start time

1 January 2013

2 references

reference URL

https://www.sec.gov/Archives/edgar/data/1551152/000104746917001778/a2231406zdef14a.htm

stated in

Form 8-K

reference URL

https://www.sec.gov/Archives/edgar/data/1551152/000104746913000017/a2212291z8-k.htm

Willie Burnside

start time

1 January 2013

2 references

reference URL

https://www.sec.gov/Archives/edgar/data/1551152/000104746917001778/a2231406zdef14a.htm

stated in

Form 8-K

reference URL

https://www.sec.gov/Archives/edgar/data/1551152/000104746913000017/a2212291z8-k.htm

Tom Freyman

start time

8 May 2020

2 references

reference URL

http://www.pharmabiz.com/NewsDetails.aspx?aid=124066&sid=2

stated in

Form 8-K

reference URL

https://www.sec.gov/Archives/edgar/data/1551152/000110465920058837/tm2018740d2_8k.htm

Brett Hart

start time

6 May 2016

1 reference

reference URL

https://www.sec.gov/Archives/edgar/data/1551152/000104746916011386/a2227878zdef14a.htm#Item1

Melody Meyer

start time

5 May 2017

2 references

reference URL

https://www.sec.gov/Archives/edgar/data/1551152/000104746918001843/a2234787zdef14a.htm

stated in

Proxy Statement

reference URL

https://www.sec.gov/Archives/edgar/data/1551152/000104746917001778/a2231406zdef14a.htm#PR3

Becky Roberts

start time

4 May 2018

2 references

reference URL

https://www.sec.gov/Archives/edgar/data/1551152/000104746918001843/a2234787zdef14a.htm

stated in

Proxy Statement

reference URL

https://www.sec.gov/Archives/edgar/data/1551152/000104746918001843/a2234787zdef14a.htm#A3

Glenn Tilton

start time

1 January 2013

2 references

reference URL

https://www.sec.gov/Archives/edgar/data/1551152/000104746917001778/a2231406zdef14a.htm

stated in

Form 8-K

reference URL

https://www.sec.gov/Archives/edgar/data/1551152/000104746913000017/a2212291z8-k.htm

Rick Waddell

start time

29 November 2012

2 references

reference URL

https://www.sec.gov/Archives/edgar/data/1551152/000104746918001843/a2234787zdef14a.htm

stated in

Form 8-K

reference URL

https://www.sec.gov/Archives/edgar/data/1551152/000104746913000017/a2212291z8-k.htm

Robert A. Michael

start time

1 July 2024

1 reference

stated in

Form 8-K

reference URL

https://www.sec.gov/Archives/edgar/data/1551152/000110465924025262/tm246649d1_ex99-1.htm

Jennifer L. Davis

start time

11 October 2023

1 reference

stated in

Form 8-K

reference URL

https://www.sec.gov/Archives/edgar/data/1551152/000110465923108864/tm2328138d1_8k.htm

Susan Quaggin

start time

11 October 2023

1 reference

stated in

Form 8-K

reference URL

https://www.sec.gov/Archives/edgar/data/1551152/000110465923108864/tm2328138d1_8k.htm

Edward J. Rapp

start time

1 January 2013

1 reference

stated in

Form 8-K

reference URL

https://www.sec.gov/Archives/edgar/data/1551152/000104746913000017/a2212291z8-k.htm

country

United States of America

1 reference

GRID ID

grid.431072.3

retrieved

22 June 2020

reference URL

https://www.grid.ac/institutes/grid.431072.3

stated in

GRID

member of

European Federation of Pharmaceutical Industries and Associations

1 reference

reference URL

https://www.efpia.eu/about-us/membership/

retrieved

7 April 2021

legal form

public company

2 references

stated in

Legal Entity Identifier

retrieved

17 March 2020

reference URL

https://fortune.com/company/abbvie/

conglomerate

0 references

total revenue

33,266,000,000 United States dollar

point in time

2019

1 reference

reference URL

https://www.sec.gov/ix?doc=/Archives/edgar/data/1551152/000155115222000007/abbv-20211231.htm

stated in

Form 10-K

45,804,000,000 United States dollar

point in time

2020

1 reference

reference URL

https://www.sec.gov/ix?doc=/Archives/edgar/data/1551152/000155115222000007/abbv-20211231.htm

stated in

Form 10-K

56,197,000,000 United States dollar

point in time

2021

1 reference

reference URL

https://www.sec.gov/ix?doc=/Archives/edgar/data/1551152/000155115222000007/abbv-20211231.htm

stated in

Form 10-K

17,444,000,000 United States dollar

point in time

2011

1 reference

reference URL

https://www.sec.gov/Archives/edgar/data/0001551152/000104746914001154/a2217723z10-k.htm

publication date

21 February 2014

stated in

Form 10-K

18,380,000,000 United States dollar

point in time

2012

1 reference

reference URL

https://www.sec.gov/Archives/edgar/data/0001551152/000104746915000995/a2223058z10-k.htm

publication date

20 February 2015

stated in

Form 10-K

18,790,000,000 United States dollar

point in time

2013

1 reference

reference URL

https://www.sec.gov/Archives/edgar/data/0001551152/000104746916010239/a2227341z10-k.htm

publication date

19 February 2016

stated in

Form 10-K

19,960,000,000 United States dollar

point in time

2014

1 reference

reference URL

https://www.sec.gov/Archives/edgar/data/0001551152/000155115217000004/abbv-12312016x10k.htm

publication date

17 February 2017

stated in

Form 10-K

22,859,000,000 United States dollar

point in time

2015

1 reference

reference URL

https://www.sec.gov/Archives/edgar/data/0001551152/000155115218000014/abbv-20171231x10k.htm

publication date

16 February 2018

stated in

Form 10-K

25,638,000,000 United States dollar

point in time

2016

1 reference

reference URL

https://www.sec.gov/Archives/edgar/data/0001551152/000155115219000008/abbv-20181231x10k.htm

publication date

27 February 2019

stated in

Form 10-K

28,216,000,000 United States dollar

point in time

2017

1 reference

reference URL

https://www.sec.gov/Archives/edgar/data/0001551152/000155115220000007/abbv-20191231x10k.htm

publication date

21 February 2020

stated in

Form 10-K

32,753,000,000 United States dollar

point in time

2018

1 reference

reference URL

https://www.sec.gov/Archives/edgar/data/0001551152/000155115221000008/abbv-20201231.htm

publication date

19 February 2021

stated in

Form 10-K

58,054,000,000 United States dollar

point in time

2022

1 reference

reference URL

https://www.sec.gov/Archives/edgar/data/0001551152/000155115223000011/abbv-20221231.htm

publication date

17 February 2023

stated in

Form 10-K

net profit

1,774,000,000 United States dollar

point in time

2014

1 reference

reference URL

https://www.sec.gov/Archives/edgar/data/0001551152/000155115217000004/abbv-12312016x10k.htm

publication date

17 February 2017

stated in

Form 10-K

5,144,000,000 United States dollar

point in time

2015

1 reference

reference URL

https://www.sec.gov/Archives/edgar/data/0001551152/000155115218000014/abbv-20171231x10k.htm

publication date

16 February 2018

stated in

Form 10-K

5,953,000,000 United States dollar

point in time

2016

1 reference

reference URL

https://www.sec.gov/Archives/edgar/data/0001551152/000155115219000008/abbv-20181231x10k.htm

publication date

27 February 2019

stated in

Form 10-K

5,309,000,000 United States dollar

point in time

2017

1 reference

reference URL

https://www.sec.gov/Archives/edgar/data/0001551152/000155115220000007/abbv-20191231x10k.htm

publication date

21 February 2020

stated in

Form 10-K

5,687,000,000 United States dollar

point in time

2018

1 reference

reference URL

https://www.sec.gov/Archives/edgar/data/0001551152/000155115221000008/abbv-20201231.htm

publication date

19 February 2021

stated in

Form 10-K

7,882,000,000 United States dollar

point in time

2019

1 reference

reference URL

https://www.sec.gov/Archives/edgar/data/0001551152/000155115222000007/abbv-20211231.htm

publication date

18 February 2022

stated in

Form 10-K

4,616,000,000 United States dollar

point in time

2020

1 reference

reference URL

https://www.sec.gov/Archives/edgar/data/0001551152/000155115223000011/abbv-20221231.htm

publication date

17 February 2023

stated in

Form 10-K

11,542,000,000 United States dollar

point in time

2021

1 reference

reference URL

https://www.sec.gov/Archives/edgar/data/0001551152/000155115223000011/abbv-20221231.htm

publication date

17 February 2023

stated in

Form 10-K

11,836,000,000 United States dollar

point in time

2022

1 reference

reference URL

https://www.sec.gov/Archives/edgar/data/0001551152/000155115223000011/abbv-20221231.htm

publication date

17 February 2023

stated in

Form 10-K

operating income

3,620,000,000 United States dollar

point in time

2011

1 reference

reference URL

https://www.sec.gov/Archives/edgar/data/0001551152/000104746914001154/a2217723z10-k.htm

publication date

21 February 2014

stated in

Form 10-K

5,817,000,000 United States dollar

point in time

2012

1 reference

reference URL

https://www.sec.gov/Archives/edgar/data/0001551152/000104746915000995/a2223058z10-k.htm

publication date

20 February 2015

stated in

Form 10-K

5,664,000,000 United States dollar

point in time

2013

1 reference

reference URL

https://www.sec.gov/Archives/edgar/data/0001551152/000104746916010239/a2227341z10-k.htm

publication date

19 February 2016

stated in

Form 10-K

3,411,000,000 United States dollar

point in time

2014

1 reference

reference URL

https://www.sec.gov/Archives/edgar/data/0001551152/000155115217000004/abbv-12312016x10k.htm

publication date

17 February 2017

stated in

Form 10-K

7,537,000,000 United States dollar

point in time

2015

1 reference

reference URL

https://www.sec.gov/Archives/edgar/data/0001551152/000155115218000014/abbv-20171231x10k.htm

publication date

16 February 2018

stated in

Form 10-K

9,340,000,000 United States dollar

point in time

2016

1 reference

reference URL

https://www.sec.gov/Archives/edgar/data/0001551152/000155115219000008/abbv-20181231x10k.htm

publication date

27 February 2019

stated in

Form 10-K

9,545,000,000 United States dollar

point in time

2017

1 reference

reference URL

https://www.sec.gov/Archives/edgar/data/0001551152/000155115220000007/abbv-20191231x10k.htm

publication date

21 February 2020

stated in

Form 10-K

6,383,000,000 United States dollar

point in time

2018

1 reference

reference URL

https://www.sec.gov/Archives/edgar/data/0001551152/000155115221000008/abbv-20201231.htm

publication date

19 February 2021

stated in

Form 10-K

12,983,000,000 United States dollar

point in time

2019

1 reference

reference URL

https://www.sec.gov/Archives/edgar/data/0001551152/000155115222000007/abbv-20211231.htm

publication date

18 February 2022

stated in

Form 10-K

11,363,000,000 United States dollar

point in time

2020

1 reference

reference URL

https://www.sec.gov/Archives/edgar/data/0001551152/000155115223000011/abbv-20221231.htm

publication date

17 February 2023

stated in

Form 10-K

17,924,000,000 United States dollar

point in time

2021

1 reference

reference URL

https://www.sec.gov/Archives/edgar/data/0001551152/000155115223000011/abbv-20221231.htm

publication date

17 February 2023

stated in

Form 10-K

18,117,000,000 United States dollar

point in time

2022

1 reference

reference URL

https://www.sec.gov/Archives/edgar/data/0001551152/000155115223000011/abbv-20221231.htm

publication date

17 February 2023

stated in

Form 10-K

location of formation

Delaware

1 reference

stated in

Legal Entity Identifier

retrieved

17 March 2020

has subsidiary

AbbVie (Germany)

0 references

AbbVie (Bermuda)

0 references

AbbVie (Bahamas)

0 references

AbbVie GK

0 references

headquarters location

North Chicago

0 references

stock exchange

New York Stock Exchange

ticker symbol

ABBV

start time

2 January 2013

2 references

imported from Wikimedia project

English Wikipedia

Wikimedia import URL

https://en.wikipedia.org/wiki/Category:Companies_listed_on_the_New_York_Stock_Exchange

retrieved

21 February 2023

product or material produced or service provided

medication

1 reference

imported from Wikimedia project

English Wikipedia

Wikimedia import URL

https://en.wikipedia.org/w/index.php?title=AbbVie_Inc.&oldid=939174101

medical treatment

0 references

official website

http://www.abbvie.com

language of work or name

English

1 reference

imported from Wikimedia project

Italian Wikipedia

separated from

Abbott Laboratories

start time

1 January 2013

1 reference

stated in

Form 8-K

reference URL

https://www.sec.gov/Archives/edgar/data/1551152/000104746913000017/a2212291z8-k.htm

social media followers

68,170

X numeric user ID

531892451

point in time

2 January 2021

0 references

74,470

X numeric user ID

531892451

point in time

28 February 2022

0 references

78,227

X numeric user ID

531892451

point in time

6 February 2023

0 references

press information URL

https://news.abbvie.com/presskits.cfm

language of work or name

English

1 reference

reference URL

https://news.abbvie.com/presskits.cfm

title

Press Kits | AbbVie News Center (English)

retrieved

22 January 2023

Commons category

AbbVie Inc.

0 references

Identifiers

Legal Entity Identifier

FR5LCKFTG8054YNNRU85

0 references

ISIN

US00287Y1091

1 reference

imported from Wikimedia project

German Wikipedia

ISO 9362 SWIFT/BIC code

ABBVUS44XXX

1 reference

reference URL

https://www.gleif.org/content/4-lei-data/8-lei-mapping/1-download-bic-to-lei-relationship-files/bic_lei_gleif_v1_monthly_full_20200327.csv

publication date

27 March 2020

VIAF ID

1457155191921682440005

1 reference

stated in

Integrated Authority File

GND ID

1179216946

retrieved

12 October 2022

ISNI

0000000405724227

1 reference

DOI

10.6084/M9.FIGSHARE.4539889

GND ID

1179216946

1 reference

stated in

Virtual International Authority File

VIAF ID

1457155191921682440005

retrieved

12 October 2022

Central Index Key

0001551152

1 reference

Wikimedia import URL

https://en.wikipedia.org/w/index.php?title=List_of_S%26P_500_companies&oldid=986445016

imported from Wikimedia project

English Wikipedia

Corporate Number (Japan)

8010003017396

0 references

Crunchbase organization ID

abbvie

0 references

EU Transparency Register ID

934069612666-51

1 reference

stated in

EU Transparency Register

EU Transparency Register ID

934069612666-51

retrieved

1 August 2023

Facebook username

AbbVieGlobal

0 references

Freebase ID

/m/0rzs09c

0 references

Genius artist ID

Abbvie-formerly-a-division-of-abbott-pharmaceuticals

0 references

Golden ID

AbbVie_Inc.-5EAJB8

1 reference

retrieved

10 September 2022

reference URL

https://golden.com/wiki/AbbVie_Inc.-5EAJB8

Google Scholar organization ID

12853406975335582193

0 references

Great Russian Encyclopedia portal ID

abbvie-e4d6bf

0 references

GRID ID

grid.431072.3

2 references

stated in

GRID Release 2015-12-14

stated in

GRID Release 2016-12-06

Instagram username

abbvie

has characteristic

verified account or profile

subject named as

AbbVie

0 references

LinkedIn company or organization ID

abbvie

0 references

Open Funder Registry funder ID

100006483

1 reference

DOI

10.6084/M9.FIGSHARE.4539889

PermID

5037613143

0 references

Ringgold ID

359181

1 reference

stated in

Aligned ISNI and Ringgold identifiers for institutions

ROR ID

02g5p4n58

0 references

X username

abbvie

X numeric user ID

531892451

has characteristic

verified account or profile

point in time

29 February 2020

start time

21 March 2012

0 references

YouTube channel ID

UC023GwYXeUQQ6TYHlCaxjOA

subject named as

AbbVie France

number of subscribers

552

number of works

47

number of viewers/listeners

141,254

start time

2 February 2016

point in time

31 October 2021

0 references

 

Sitelinks

Wikipedia(22 entries)

• arwiki شركة أب في
• arzwiki شركة اب فى
• dawiki AbbVie
• dewiki Abbvie
• enwiki AbbVie
• eowiki AbbVie
• eswiki AbbVie
• fawiki اب‌وی
• fiwiki AbbVie
• frwiki AbbVie
• hewiki אבווי
• idwiki AbbVie
• itwiki AbbVie
• jawiki アッヴィ
• kowiki 애브비
• mswiki AbbVie
• ruwiki AbbVie
• sahwiki Abbvie
• svwiki Abbvie
• ukwiki AbbVie
• uzwiki AbbVie
• zhwiki 艾伯维

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q14662364&oldid=2188163717"